Skip to main content
micro-community-banner
 
  • Saved

made a Post

Comparison of patient- and clinician-reported outcome measures in lower back rehabilitation: introducing a new integrated performance measure (t2D)

Purpose Patient- and clinician-reported outcome measures (PROMs, CROMs) are used in rehabilitation to evaluate and track the patient's health status and recovery. However, controversy still exists regarding their relevance and ..... see more

Source : https://link.springer.com/article/10.1007/s11136-021-02905-2

  • Saved

made a Post

Research shows resistance training can help reduce type 2 diabetes risk

A group of Oakland University researchers used data from medical studies around the world to examine the impact of resistance training on type 2 diabetes risk. see more

Source : https://medicalxpress.com/news/2021-06-resistance-diabetes.html

  • Saved

made a Post

Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis - PubMed

1 Melbourne EpiCentre, University of Melbourne and Melbourne Health, Parkville, Victoria, Australia sambhupaul@hotmail.com. 2 Melbourne EpiCentre, University of Melbourne and Melbourne Health, Parkville, Victoria, Australia. 3 Pharmaceuticals Division, Genentech, South ..... see more

Source : https://pubmed.ncbi.nlm.nih.gov/34135030/

Gerrie Shiver, Martin Hauptschein Commented on a Post
  • Saved

Advancing oral treatment for Type 2 diabetes

Your obese type 2 diabetes patient, who is 58 years old, has been on metformin, but recent HbA1C levels are around 8.2%, despite attempts at controlling diet and exercise. The patient realizes something must be done and would very much like to maximize A1C reductions with the next option, hoping to achieve levels closer to a goal of 7.0%, if not below that, to avoid having to add multiple further medications. However, the patient hopes to avoid injectable medications if they are not completely necessary. The patient would also like to lose weight.

What medication would you recommend next?

Would your recommendation differ if the patient had a history of atherosclerotic cardiovascular disease?

How would you help this patient stay compliant with your prescribed treatment regimen?

Show More Comments

  • 4 days 2 hours
    Would use an oral GLP-1 agent. Other option would be an SGLT2-Inhibitor. Either class has been shown to have MACE data.
  • 1 week 3 days
    this is a set up for rybelsus orally as weight may be lost if takend correctly without injection of a glp1
  • Saved

made a Post

Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms - PubMed

This population-based cohort study identified associations between GA and baseline diabetes and hyperlipidemia as well as between GA and both baseline and incident autoimmune conditions. These findings suggest that diabetes ..... see more

Source : https://pubmed.ncbi.nlm.nih.gov/34106218/

Robin Kollman Commented on a Post
  • Saved

Non-insulin treatment for A1C reduction in Type 2 diabetes

Current ADA guidelines recommend:

  • A1C goal for nonpregnant adults of <7% (53 mmol/mol) without significant hypoglycemia is appropriate.
  • Achievement of lower A1C levels than 7% may be acceptable, and even beneficial, if achieved safely without significant hypoglycemia or other adverse effects.
  • A1C goals of <8% [64 mmol/mol] or higher may be appropriate for patients with limited life expectancy, or where the risks outweigh the benefits.


Current ADA guidelines recommend that the medication regimen and medication-taking behavior should be reevaluated at regular intervals (every 3–6 months) and adjusted as needed to incorporate specific factors that impact treatment choice.

How long after starting a diabetes medication do you wait to see if the patient needs to switch or escalate to other non-insulin anti-diabetic treatments?

What are the key considerations when deciding to switch or escalate to other non-insulin anti-diabetic treatments?

Show More Comments

  • 1 week
    Recheck patient in 4 weeks
  • 1 week
    When starting new medicine will have patient back in 4 weeks to see how they are doing with medication Will review blood glucose record if they are keeping one If tolerating Show More
  • Saved

made a Post

Associations Between Fruit Intake and Risk of Diabetes in the AusDiab Cohort

Type 2 diabetes mellitus (T2DM) is characterized by impaired insulin secretion (β-cell dysfunction) and increased insulin resistance (or resistance to insulin mediated glucose uptake). It accounts for more than 2 ..... see more

Source : https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgab335/6290732

  • Saved

made a Post

Habitual intake of dietary L-arginine in relation to risk of type 2 diabetes: a prospective study

Background There are insufficient data in case of the potential association of habitual dietary L-arginine and the risk of type 2 diabetes mellitus (T2DM) incidence. Here we aimed to examine ..... see more

Source : https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-021-00774-x

  • Saved

made a Post

Adolescent Thyroid disorders and Risk for Type 2 Diabetes in Young Adulthood

AbstractCONTEXT. Thyroid hormones play a key role in systemic metabolism, yet the relationship between thyroid dysfunction and risk for type 2 diabetes is uncle see more

Source : https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgab382/6288474

  • Saved

made a Post

Association of crossing capillaries in the finger nailfold with diabetic retinopathy in type 2 diabetes mellitus

Maiko Shikama , Junji Kozawa , Norikazu Maeda , Michio Otsuki , Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan Search for more papers by this ..... see more

Source : https://onlinelibrary.wiley.com/doi/full/10.1111/jdi.13444

  • Saved

made a Post

The relationship of coffee consumption and CVD risk factors in elderly patients with T2DM

Objective Clinical studies suggest increasing prevalence of cardiovascular disease (CVD) risk factors and diabetes among the elderly. Meanwhile, some food compounds, such as coffee, can also have beneficial effects on ..... see more

Source : https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02058-7

  • Saved

made a Post

Long-term variability of blood pressure and incidence of heart failure among individuals with Type 2 diabetes - PubMed

doi: 10.1002/ehf2.13385. Online ahead of print. 1 Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA. 2 Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins ..... see more

Source : https://pubmed.ncbi.nlm.nih.gov/34032375/

  • Saved

made a Post

A Meta-Analysis of the Effects of Glucagon-Like-Peptide 1 Receptor Agonist (GLP1-RA) in Nonalcoholic Fatty Liver Disease (NAFLD) With Type 2 Diabetes (T2D)

Introduction: Treatment options for nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D), two conditions which coexist, are limited though weight loss is an important strategy to improve outcomes ..... see more

Source : https://europepmc.org/article/ppr/ppr349051

  • Saved

made a Post

Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial - PubMed

Increases of VVV were associated with the risk of CV events in Japanese patients with T2DM independent of mean-HbA1c. The long-term variability of HbA1c as well as mean HbA1c might ..... see more

Source : https://pubmed.ncbi.nlm.nih.gov/34013644/

  • Saved

made a Post

The retinopathy-derived glycated hemoglobin threshold of 6.5% for type 2 diabetes also captures the risk of diabetic nephropathy in NHANES - PubMed

A clinically useful diagnostic threshold below 6.5% for HbA1c for elevated UACR risk was not identified, with increased risk only obvious at HbA1c ≥ 7.0%. Thus, the retinopathy-derived HbA1c threshold ..... see more

Source : https://pubmed.ncbi.nlm.nih.gov/34033191/

  • Saved

made a Post

Geographically weighted machine learning model for untangling spatial heterogeneity of type 2 diabetes mellitus (T2D) prevalence in the USA

Type 2 diabetes mellitus (T2D) prevalence in the United States varies substantially across spatial and temporal scales, attributable to variations of socioeconomic and lifestyle risk factors. Understanding these variations in ..... see more

Source : https://www.nature.com/articles/s41598-021-85381-5